- Home
- YSG vs CATX Comparison
YSG vs CATX Comparison
Compare YSG & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YSG | CATX |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.9M | 355.0M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | YSG | CATX |
|---|---|---|
| Price | $2.66 | $3.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.11 |
| AVG Volume (30 Days) | 62.7K | ★ 948.3K |
| Earning Date | 05-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.08 | N/A |
| Revenue Next Year | $9.45 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.15 | $1.96 |
| 52 Week High | $10.28 | $6.16 |
Technical Indicators
Market Signals| Indicator | YSG | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 24.11 | 47.17 |
| Support Level | $2.15 | $2.82 |
| Resistance Level | $3.49 | $3.56 |
| Average True Range (ATR) | 0.18 | 0.16 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 4.29 | 11.21 |
Price Performance
Historical ComparisonAbout YSG Yatsen Holding Limited
Yatsen Holding Ltd is engaged in the retail business of beauty products, skincare items, and other cosmetic products. The group's principal operations are currently organized into three segments on a product category basis, namely Color Cosmetics Brands, Skincare Brands, and others. The company's majority of revenue is generated from sales of Color Cosmetics Brands. Geographically, company operates in PRC, Europe and US regions.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.